It will focus on the importance of clinical data in bringing cell-based therapies to market, the role of clinical data at every step of the process, the importance of involving regulators early and often in the pathway to market as well as the players in reimbursement in this field and how are they responding to these new approaches.
http://ift.tt/1paQUQf
http://ift.tt/1paQUQf
No comments:
Post a Comment